Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-11
1993-04-27
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 99, C07D22114, A61K 31435
Patent
active
052062490
ABSTRACT:
This invention relates to bis-naphthalimides, including 2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-be nz[de]isoquinoline-1,3(2H)-dione] and 2,2'-[1,2-ethanediylbis[imino(2-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-be nz[de]isoquinoline-1,3(2H)-dione], processes for their preparation, pharmaceutical compositions containing them, and methods of using them to treat cancer in mammals.
REFERENCES:
patent: 4665071 (1987-05-01), Zee-Cheng et al.
patent: 4874863 (1989-10-01), Brana et al.
patent: 4919848 (1990-04-01), Harnisch
patent: 5086059 (1992-02-01), Ardecky et al.
Daus Donald G.
Du Pont Merck Pharmaceutical Company
Ferguson Blair Q.
LandOfFree
Bis-naphthalimides containing amino-acid derived linkers as anti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-naphthalimides containing amino-acid derived linkers as anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-naphthalimides containing amino-acid derived linkers as anti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2327323